Article

B + L appoints Grant for surgical business

Bausch + Lomb has named Robert E. Grant chief executive officer and president of its global surgical business, effective Aug. 1.

Rochester, NY-Bausch + Lomb has named Robert E. Grant chief executive officer (CEO) and president of its global surgical business, effective Aug. 1.

He will be based in Aliso Viejo, CA.

Grant joins Bausch + Lomb from Allergan, a company he joined in 2006 as corporate vice president and president of Allergan Medical. Before joining Allergan, Grant was acting chairman, president, and CEO of Biolase Technology, a cosmetic dentistry company, where he led a turnaround effort. He had joined Biolase in 2003 as chief operating officer and also served the organization as chief financial officer.

From 1997 to 2003, Grant held management positions with Lumenis (formerly Coherent Medical Group), including that of executive vice president of its ophthalmic business unit, executive vice president of its surgical business unit, vice president of business development, and managing director of European operations. His career also has included expatriate management positions with Sulzer Medica AG and Telectronics Pty Ltd.

Grant succeeds J. Andy Corley, who has been president of Bausch + Lomb surgical business since 2008. He will transition into a role as senior adviser to Bausch + Lomb CEO Brent Saunders and the company’s senior leadership team.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.